Sangamo therapeutics, inc. (SGMO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating Activities:
Net loss

-96,190

-95,419

-119,139

-104,621

-90,905

-68,889

-62,761

-62,272

-58,123

-54,568

-51,101

-57,712

-71,796

-71,658

-76,047

-66,327

-51,878

-40,703

-31,009

-29,309

-24,164

-26,417

-30,242

-28,842

-27,311

-26,624

-21,958

-21,603

-21,881

-22,264

-25,145

-28,909

-33,440

-35,750

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

4,496

3,900

3,474

2,776

2,527

2,400

2,138

2,089

1,787

1,500

1,282

1,122

1,053

997

988

1,053

1,086

988

894

727

573

549

524

514

545

569

605

631

639

660

667

661

652

646

0

0

0

Amortization of discount on marketable securities

4,214

4,708

5,501

6,628

6,608

5,829

4,406

2,361

1,192

673

248

-120

-209

-221

-305

-496

-658

-827

-936

-979

-1,044

-1,098

-1,130

-1,951

-1,438

-912

-2,206

-923

-930

-889

1,031

1,280

1,528

1,576

0

0

0

Amortization and other changes in right-of-use assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on free shares

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

20,427

19,330

18,394

17,503

16,150

14,677

12,494

10,902

9,351

9,089

8,898

9,415

14,651

15,057

16,194

16,287

11,971

11,730

11,699

11,000

10,246

9,200

8,213

7,475

6,724

6,146

5,425

5,438

5,284

5,338

6,110

6,759

7,501

8,081

0

0

0

Net loss on lease termination

0

-218

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,800

-1,700

-1,650

-1,620

230

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Intangible impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,870

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Benefit from income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,722

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Build-to-suit leases

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

0

-

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net changes in operating assets and liabilities:
Interest receivable

332

307

-3

204

221

135

200

306

-25

16

173

-43

-4

-83

-89

-94

4

-116

86

82

15

85

105

38

125

148

-103

74

-112

-141

-231

-310

-22

-6

0

0

0

Accounts receivable

-341

32,236

16,385

7,118

3,736

1,330

2,135

1,482

1,174

-1,629

1,644

883

-473

2,144

-5,522

-2,874

-4,071

-7,847

-1,470

-1,790

1,278

7,213

3,615

2,017

1,743

-1,008

1,525

1,881

2,279

3,414

2,351

1,860

38

553

0

0

0

Prepaid expenses and other assets

7,912

6,660

5,711

4,713

342

2,828

1,777

3,194

2,073

669

1,130

1,641

1,214

1,112

478

3

-447

-376

-930

-687

86

258

1,152

803

612

480

9

471

-15

-14

113

-75

1

13

0

0

0

Prepaid rent

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

-14,030

-4,192

-8,914

-7,294

3,888

-6,372

332

3,298

3,560

3,219

3,260

1,551

2,405

-2,335

-149

-2,445

-3,445

-764

-1,829

3,444

115

4,324

5,511

2,592

3,756

544

919

645

87

-1,503

-721

-1

-63

-139

0

0

0

Accrued compensation and employee benefits

2,470

4,129

3,085

2,973

1,566

2,604

2,132

1,437

1,172

2,594

1,637

707

317

137

58

182

19

-105

115

47

232

-341

625

530

337

721

207

148

137

800

474

292

130

315

0

0

0

Deferred revenues

-43,642

-35,693

-39,653

-49,931

96,293

99,364

111,446

123,112

52,555

48,984

54,951

61,531

-4,860

-5,214

-7,559

-7,052

-9,638

-8,380

-6,531

-7,653

-5,616

13,238

14,301

16,044

17,258

-2,190

-2,314

-2,058

-2,052

11,134

11,514

11,781

12,639

-64

0

0

0

Long-term portion of lease liabilities

-2,621

-1,800

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

3,968

3,749

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-118,173

-144,402

-163,747

-152,469

9,565

36,550

59,869

71,778

6,123

11,179

16,253

14,362

-58,601

-65,883

-63,219

-59,839

-51,687

-33,720

-27,328

-18,898

-19,447

-5,675

-4,620

-3,366

-85

-19,482

-17,602

-18,247

-18,967

-8,082

-8,303

-9,612

-11,070

-25,895

0

0

0

Investing Activities:
Purchases of marketable securities

400,216

443,711

321,390

244,305

474,913

451,239

473,972

544,402

276,756

252,328

260,106

231,916

172,797

218,640

277,490

282,983

303,381

257,988

220,044

281,694

250,452

227,802

258,118

158,373

119,094

118,894

58,019

71,447

95,148

91,428

101,018

81,595

110,705

112,974

0

0

0

Maturities of marketable securities

397,669

404,847

453,445

485,432

415,648

391,845

282,129

228,943

187,625

178,675

164,093

194,439

214,227

237,497

335,183

330,713

347,676

337,861

254,335

210,396

165,934

127,765

89,350

74,313

59,005

51,129

66,699

78,770

98,560

103,470

100,693

90,976

78,794

83,412

0

0

0

Purchases of property and equipment

18,473

20,675

41,931

47,057

46,426

43,065

15,906

7,344

5,899

3,751

3,096

2,551

948

732

0

0

0

-

0

0

0

-

596

548

490

432

755

809

573

723

568

643

684

576

0

0

0

Net cash provided by (used in) investing activities

-21,282

-59,801

19,436

118,423

-181,338

-178,106

-212,970

-322,803

-95,030

-77,404

-99,109

-40,028

40,482

18,125

57,100

47,045

42,716

77,462

31,902

-73,536

-86,097

-100,658

-169,285

-84,529

-60,500

-68,118

7,925

6,514

2,839

11,319

-893

18,877

-22,456

-19,999

0

0

0

Proceeds from public offering of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

81,573

0

0

0

-

-

-

-

-

-

-

-

93,796

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Taxes paid related to net share settlement of equity awards

546

400

605

539

551

300

0

0

0

-

-

0

0

-

-

2,032

1,541

1,546

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and restricted stock units

2,383

2,044

-8,095

-7,707

-8,632

1,484

11,673

13,278

11,392

818

3,967

1,235

949

1,113

1,316

2,561

3,813

6,804

8,660

8,536

8,530

12,937

0

0

0

-

-

-

-

1,676

-48,851

-49,314

1,033

1,772

0

0

0

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

142,222

142,029

142,376

142,831

221,342

231,709

242,446

244,094

104,629

97,490

84,764

82,548

3,596

337

-182

14,981

16,724

19,710

18,508

3,932

3,977

102,177

104,801

175,113

175,231

76,107

76,262

5,309

3,815

1,676

1,253

790

51,137

51,876

0

0

0

Effects of changes in foreign exchange rates

14

184

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash, cash equivalents, and restricted cash

2,781

-61,990

-1,448

109,816

50,260

90,592

89,345

-6,931

15,722

31,265

1,908

56,882

-14,523

-47,421

-6,301

2,187

7,753

63,452

23,082

-88,502

-101,567

-4,156

-69,104

87,218

114,646

-11,493

66,585

-6,424

-12,313

4,913

-7,943

10,055

17,611

5,982

0

0

0

Supplemental disclosure of non-cash activities:
Right-of-use assets obtained in exchange for lease obligations

24,615

31,291

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License included in accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and Equipment
Capital expenditures included in unpaid liabilities

1,360

2,114

3,397

4,796

5,560

4,953

0

0

0

-

-

-

-

-

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-